Published in J Eukaryot Microbiol on April 03, 2006
Vaccines against a Major Cause of Abortion in Cattle, Neospora caninum Infection. Animals (Basel) (2011) 0.86
Adjuvant and immunostimulatory effects of a D-galactose-binding lectin from Synadenium carinatum latex (ScLL) in the mouse model of vaccination against neosporosis. Vet Res (2012) 0.78
Protection against lethal Neospora caninum infection in mice induced by heterologous vaccination with a mic1 mic3 knockout Toxoplasma gondii strain. Infect Immun (2009) 0.77
Evaluation of the protection conferred by a naturally attenuated Neospora caninum isolate against congenital and cerebral neosporosis in mice. Vet Res (2012) 0.77
Protective effect of intranasal immunization with Neospora caninum membrane antigens against murine neosporosis established through the gastrointestinal tract. Immunology (2014) 0.75
The role of nuclear technologies in the diagnosis and control of livestock diseases--a review. Trop Anim Health Prod (2012) 0.75
Source monitoring. Psychol Bull (1993) 7.46
Biological properties of RB51; a stable rough strain of Brucella abortus. Vet Microbiol (1991) 4.67
Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin Microbiol Rev (1998) 3.59
Purification and characterization of smooth and rough lipopolysaccharides from Brucella abortus. J Bacteriol (1979) 3.40
A review of Neospora caninum and neosporosis. Vet Parasitol (1996) 3.21
PATRIC: the VBI PathoSystems Resource Integration Center. Nucleic Acids Res (2006) 3.06
Dogs are definitive hosts of Neospora caninum. Int J Parasitol (1998) 2.57
Infection dynamics of Cryptosporidium parvum (Apicomplexa: Cryptosporiidae) in neonatal mice (Mus musculus). J Parasitol (1986) 2.27
Wild boars as sources for infectious diseases in livestock and humans. Philos Trans R Soc Lond B Biol Sci (2009) 1.99
Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis. Infect Immun (1994) 1.93
Enzyme-linked immunosorbent assay for bovine immunoglobulin subclass-specific response to Brucella abortus lipopolysaccharides. Infect Immun (1979) 1.93
Neonatal Neospora caninum infection in dogs: isolation of the causative agent and experimental transmission. J Am Vet Med Assoc (1988) 1.80
A versatile computational pipeline for bacterial genome annotation improvement and comparative analysis, with Brucella as a use case. Nucleic Acids Res (2007) 1.68
Genetic characterization of a Tn5-disrupted glycosyltransferase gene homolog in Brucella abortus and its effect on lipopolysaccharide composition and virulence. Infect Immun (1999) 1.62
Cloning of the Escherichia coli genes for the biosynthetic enzymes for polyamines. Methods Enzymol (1983) 1.60
Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4. Am J Vet Res (1996) 1.55
Identification of an IS711 element interrupting the wboA gene of Brucella abortus vaccine strain RB51 and a PCR assay to distinguish strain RB51 from other Brucella species and strains. Clin Diagn Lab Immunol (1999) 1.54
Monoclonal antibodies to Brucella surface antigens associated with the smooth lipopolysaccharide complex. Am J Vet Res (1984) 1.54
Antibody response to antigens distinct from smooth lipopolysaccharide complex in Brucella infection. Infect Immun (1978) 1.52
Influence of supplemental selenium on humoral immune responses in weaned beef calves. Am J Vet Res (1989) 1.51
Identification of an immunoreactive Brucella abortus HtrA stress response protein homolog. Infect Immun (1994) 1.47
Bovine veneral vibriosis: antigenic variation of the bacterium during infection. Infect Immun (1975) 1.46
Brucella abortus deficient in copper/zinc superoxide dismutase is virulent in BALB/c mice. Microb Pathog (1992) 1.45
Characterization of monoclonal antibodies directed against swine leukocytes. Vet Immunol Immunopathol (1986) 1.42
Unilateral Leydig cell tumour resulting in acute colic and scrotal swelling in a stallion with descended testes. Equine Vet J (1999) 1.40
Nucleotide sequence and analysis of the speA gene encoding biosynthetic arginine decarboxylase in Escherichia coli. J Bacteriol (1990) 1.34
Studies on cryopreservation of Cryptosporidium parvum. J Parasitol (1991) 1.34
Induction of specific cytotoxic lymphocytes in mice vaccinated with Brucella abortus RB51. Infect Immun (2001) 1.33
Analysis and sequence of the speB gene encoding agmatine ureohydrolase, a putrescine biosynthetic enzyme in Escherichia coli. J Bacteriol (1990) 1.32
Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51. Infect Immun (2000) 1.32
Cloning and sequencing of yajC and secD homologs of Brucella abortus and demonstration of immune responses to YajC in mice vaccinated with B. abortus RB51. Infect Immun (1998) 1.29
Bovine venereal vibriosis: variations in immunoglobulin class of antibodies in genital secretions and serum. Infect Immun (1974) 1.28
Bovine veneral vibriosis: cure of genital infection in females by systemic immunization. Infect Immun (1975) 1.24
Cytological and deoxyribonucleic acid-deoxyribonucleic acid hybridization studies on lactobacillus isolates from San Francisco sourdough. Appl Microbiol (1973) 1.23
Isospora suis enteritis in piglets. Vet Pathol (1980) 1.22
Complementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuation. Infect Immun (2000) 1.22
Vaccination with live Escherichia coli expressing Brucella abortus Cu/Zn superoxide dismutase protects mice against virulent B. abortus. Infect Immun (1999) 1.21
A review of Sarcocystis neurona and equine protozoal myeloencephalitis (EPM). Vet Parasitol (2001) 1.21
Superoxide dismutases of virulent and avirulent strains of Brucella abortus. Vet Microbiol (1991) 1.20
Systematic pathogenesis and replication of avian hepatitis E virus in specific-pathogen-free adult chickens. J Virol (2005) 1.20
Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses. Infect Immun (2000) 1.18
Survival of Toxoplasma gondii tachyzoites in goat milk: potential source of human toxoplasmosis. J Eukaryot Microbiol (1999) 1.18
Electroporation of a suicide plasmid bearing a transposon into Brucella abortus. Microb Pathog (1990) 1.17
Negative control of ornithine decarboxylase and arginine decarboxylase by adenosine-3':5'-cyclic monophosphate in Escherichia coli. Mol Gen Genet (1982) 1.16
Rapid identification of smooth Brucella species with a monoclonal antibody. J Clin Microbiol (1987) 1.15
Comparative behaviour of Brucella abortus strains 19 and RB51 in the pregnant mouse. Res Vet Sci (1992) 1.15
Neosporosis. Parasitol Today (1993) 1.15
Children's eyewitness reports after exposure to misinformation from parents. J Exp Psychol Appl (2001) 1.14
Molecular cloning and nucleotide sequence analysis of the gene encoding the immunoreactive Brucella abortus Hsp60 protein, BA60K. Microb Pathog (1992) 1.12
Antagonistic transcriptional regulation of the putrescine biosynthetic enzyme agmatine ureohydrolase by cyclic AMP and agmatine in Escherichia coli. J Bacteriol (1984) 1.12
Transformation of Brucella species with suicide and broad host-range plasmids. Methods Mol Biol (1995) 1.11
Neospora caninum-like protozoon associated with fatal myelitis in newborn calves. J Parasitol (1989) 1.11
A dye-based lymphocyte proliferation assay that permits multiple immunological analyses: mRNA, cytogenetic, apoptosis, and immunophenotyping studies. J Immunol Methods (1997) 1.11
Effects of long-term estrogen treatment on IFN-gamma, IL-2 and IL-4 gene expression and protein synthesis in spleen and thymus of normal C57BL/6 mice. Cytokine (2001) 1.11
Field study of vaccination of cattle with Brucella abortus strains RB51 and 19 under high and low disease prevalence. Am J Vet Res (1998) 1.10
Redescription of Neospora caninum and its differentiation from related coccidia. Int J Parasitol (2002) 1.10
Biosynthetic arginine decarboxylase in Escherichia coli is synthesized as a precursor and located in the cell envelope. J Bacteriol (1985) 1.08
Molecular mechanisms of the synergistic induction of ornithine decarboxylase by asparagine and glucagon in primary cultured hepatocytes. J Biol Chem (1987) 1.07
Deletion of wboA enhances activation of the lectin pathway of complement in Brucella abortus and Brucella melitensis. Infect Immun (2001) 1.06
Inhibition of Cryptosporidium parvum in neonatal Hsd:(ICR)BR Swiss miceby polyether ionophores and aromatic amidines. Antimicrob Agents Chemother (1991) 1.06
Characterization of specific immune responses of mice inoculated with recombinant vaccinia virus expressing an 18-kilodalton outer membrane protein of Brucella abortus. Clin Diagn Lab Immunol (2000) 1.06
Immune responses and protection against experimental challenge after vaccination of bison with Brucella abortus strain RB51 or RB51 overexpressing superoxide dismutase and glycosyltransferase genes. Clin Vaccine Immunol (2009) 1.06
Cancer surveillance in ulcerative colitis: more of the same or progress? Gastroenterology (1994) 1.06
A new Hepatozoon species from dogs: description of the causative agent of canine hepatozoonosis in North America. J Parasitol (1997) 1.04
Prevalence of antibodies to Neospora caninum, Sarcocystis neurona, and Toxoplasma gondii in wild horses from central Wyoming. J Parasitol (2003) 1.04
Confirmation that the dog is a definitive host for Neospora caninum. Vet Parasitol (1999) 1.04
Transplacental Neospora caninum infection in dogs. Am J Vet Res (1989) 1.02